cefadroxil anhydrous has been researched along with linezolid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bruss, J; Fleishaker, D; Hilty, M; Naberhuis-Stehouwer, S; Tregnaghi, M; Wible, K | 1 |
| Afghani, B; Bruss, JB; Edge-Padbury, B; Fleishaker, D; Kaplan, SL; Lopez, P; Naberhuis-Stehouwer, S; Wu, E | 1 |
| Bruss, JB; Edge-Padbury, B; Goldfarb, J; Kaplan, SA; Naberhuis-Stehouwer, S; Saiman, L; Wible, K | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
2 review(s) available for cefadroxil anhydrous and linezolid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefadroxil; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infusions, Intravenous; Linezolid; Male; Methicillin Resistance; Outpatients; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2003 |
3 trial(s) available for cefadroxil anhydrous and linezolid
| Article | Year |
|---|---|
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Adolescent; Cefadroxil; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Skin Diseases, Infectious; Treatment Outcome | 2003 |
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefadroxil; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infusions, Intravenous; Linezolid; Male; Methicillin Resistance; Outpatients; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Safety and tolerability of linezolid in children.
Topics: Acetamides; Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefadroxil; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Gram-Positive Bacterial Infections; Headache; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Multicenter Studies as Topic; Otitis Media; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Skin Diseases, Bacterial | 2003 |
5 other study(ies) available for cefadroxil anhydrous and linezolid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |